drugset
drugset / Trial / NCT02273479

Pharmacokinetics and Safety of Asasantin Extended Release (RAD-SP) Capsules in Japanese Healthy Male Volunteers

NCT02273479 ↗

Phase 1 Completed 32 enrolled Boehringer Ingelheim
RandomizedParallel-groupDouble-blindTreatment

Summary

Study to investigate pharmacokinetics, pharmacodynamics and safety of RAD-SP capsule in multiple administration to healthy adult male volunteers.

Timeline

Start
1999-07
Primary completion
1999-09
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Asasantin® Unknown — —

Indications

No indication recorded.